Emd Serono Research & Development Institute, Inc.
Clinical trials sponsored by Emd Serono Research & Development Institute, Inc., explained in plain language.
-
New lupus skin rash pill enters final testing phase
Disease control Not yet recruitingThis study aims to see if a new pill called enpatoran can safely reduce skin rashes and symptoms in people with lupus. About 202 participants with active lupus skin disease will take either the drug or a placebo pill for 24 weeks while continuing their standard lupus medications.…
Phase: PHASE3 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New pill aims to tame painful lupus skin flares in major trial
Disease control Not yet recruitingThis study aims to see if a new oral medication called enpatoran is effective and safe for treating active skin rashes caused by lupus. It will involve about 202 adults with cutaneous lupus, who may or may not also have systemic lupus. Participants will take either the study drug…
Phase: PHASE3 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New pill aims to tame painful lupus skin flares
Disease control Not yet recruitingThis study is testing whether a pill called enpatoran can safely reduce active skin rashes in people with lupus. About 202 participants with moderate-to-severe lupus skin symptoms will take either enpatoran or a placebo pill for 24 weeks, while continuing their standard lupus med…
Phase: PHASE3 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC